Transaction · 0001193125-26-390624

Cobo Marc

Cobo Marc, PAO, reported a transaction classified as grant at BridgeBio Oncology Therapeutics, Inc. involving 43700.000000 shares for an estimated $0.00. Reported holdings after the transaction were 43700.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APAO
BBOTBridgeBio Oncology Therapeutics, Inc.
Trade date
Sep 10, 2026
Filing date
Sep 14, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded43.7k$0.00 per share
Holdings after43.7kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

BBOT price since this filing

Daily closing prices, with the filing date and available return windows
BBOT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -1.8%1w ago +0.0%1d ago +0.0%
Returns since7d -50.2%30d -69.0%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-390624
Stock Option (Right to Buy)
Transaction date
Sep 10, 2026
Filed Sep 14, 2026, 08:24 PM · 4d delay
Shares
43,700 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
43,700 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Principal Accounting Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents a grant of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a p…

  2. F2

    Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of RSUs.

  3. F3

    1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 21, 2026, subject to the Reporting Person's con…

Original filing · 0001193125-26-390624
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BBOT